Autosomal dominant cerebellar ataxia, deafness and narcolepsy
MONDO:0011397Autosomal dominant cerebellar ataxia, deafness and narcolepsy (ADCA-DN) is a polymorphic disorder and a subtype of autosomal dominant cerebellar ataxia type 1 (ADCA type 1) characterized by ataxia, sensorineural deafness and narcolepsy with cataplexy and dementia.
Also known as: ADCA-DN syndrome, autosomal dominant cerebellar ataxia, deafness and narcolepsy, ADCA-DN, ADCADN, autosomal dominant cerebellar ataxia, deafness, and narcolepsy, autosomal dominant cerebellar ataxia-deafness-narcolepsy syndrome, cerebellar ataxia, deafness, and narcolepsy, autosomal dominant
47 clinical trials for this condition and its sub-types, 0 tagged with Autosomal dominant cerebellar ataxia, deafness and narcolepsy itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Magnetic pulses to the brain may help lung cancer patients sleep after surgery
Symptom relief Not yet recruitingThis trial tests whether low-frequency repetitive transcranial magnetic stimulation (rTMS) can improve sleep quality in adults undergoing surgery for lung cancer. Participants with poor sleep before surgery will receive either active rTMS or a sham (inactive) treatment over five …
Phase 2 • Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC
-
Magnetic pulses to the brain may help lung transplant patients sleep
Symptom relief Not yet recruitingThis trial tests whether low-frequency repetitive transcranial magnetic stimulation (rTMS) can improve sleep quality in adults recovering from a lung transplant. Participants with sleep problems during their hospital stay will receive either active rTMS or a sham (inactive) treat…
Phase 2 • Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC
-
A sip for better sleep? beverage put to the test
Symptom relief Not yet recruitingThis trial tests whether a concentrated beverage taken daily for 28 days can improve sleep quality in adults aged 18 to 60 with mild sleep issues. Participants keep sleep diaries and complete questionnaires on sleep quality and fatigue. The study uses a single-arm design, meaning…
Sponsor: Sirio Pharma Co., Ltd • Aim: Symptom relief
Last updated Jul 26, 2026 00:00 UTC
-
Can intense walking training help brain injury patients walk better?
Symptom relief Not yet recruitingThis study looks at whether high-intensity walking training can help people with cerebellar damage (a part of the brain that controls balance and coordination) improve their walking ability. Twenty participants will either do intense walking exercises or standard training. The go…
Sponsor: Indiana University • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
Can a narcolepsy drug fix ICU sleep problems?
Symptom relief Not yet recruitingThis study tests whether a drug called gamma-hydroxybutyrate (GHB) can help intensive care patients get better deep sleep. Sleep problems are very common in the ICU and can lead to serious issues like confusion and longer recovery. The trial will give GHB or a placebo to 24 adult…
Phase 2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
Can a bedtime pill fix sleep troubles in kids with anorexia?
Symptom relief Not yet recruitingThis study tests a slow-release melatonin (PedPRM) in 120 children aged 6 to 18 who have anorexia nervosa and trouble sleeping. Participants take either melatonin or a placebo for 13 weeks. The goal is to see if it safely improves total sleep time and related symptoms like anxiet…
Phase 3 • Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
AI vs. experts: can a computer judge speech as well as a human?
Knowledge-focused Not yet recruitingThis study will compare how well an AI program (Blings) measures speech clarity in 40 adults with speech disorders from stroke or other neurological conditions. Two speech therapists will also rate the same speech samples. The goal is to see if the AI can reliably replace or assi…
Sponsor: Pusan National University Yangsan Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC